Cera stock

Overview

Cera is a UK-based digital health company that uses technology to deliver and manage home healthcare, providing carers, nurses, and remote monitoring to elderly patients in their homes.

Selling Cera shares

Why shareholders consider selling

Shareholders in Cera may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, Cera does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.

Can you sell Cera stock?

Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Healthcare & Biotech sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing Cera shares would be outlined in the holder's equity agreement or the company's governing documents.

What affects the value of Cera shares?

The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Healthcare & Biotech market conditions, and any recent private-market transaction activity. Data points such as the company's Series C round and its reported $1B valuation can help frame expectations, though they do not guarantee a transaction price.

What should holders check before selling

• The type of security held (common shares, preferred, options, RSUs)
• Whether the equity is fully vested and, for options, whether it has been exercised
• Any transfer restrictions, lock-up provisions, or company approval requirements
• Estimated net proceeds after applicable taxes and transaction fees
• Whether partial liquidity — selling a portion rather than the full position — may be a better fit

Tools for Cera shareholders

Exploring equity in Cera often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.

Latest funding round

Cera most recently raised a Series C round . The company was valued at $1B. Total funding raised to date is approximately $400M.

Cera funding history

Cera IPO & exit outlook

Cera has not announced a confirmed IPO date or acquisition. At the Series C stage, most companies are still years away from a public listing or acquisition. Founded 2016, Cera has been private for 10 years.

For employees holding equity, the timeline to liquidity is uncertain. Options to consider include:

• Secondary-market sales — selling vested shares to outside buyers
• Company-sponsored tender offers — periodic buyback programs some late-stage companies run
• Early exercise and 83(b) elections — strategies to reduce future tax exposure while waiting for liquidity

Read our liquidity guide for a full comparison of paths to liquidity.

Founders & company background

Cera was founded in 2016 by Ben Maruthappu, Mahiben Maruthappu and is headquartered in London, United Kingdom.

Industry

• Healthcare & Biotech

Similar private companies

Latest Cera news

Q4 Results 08th May Highlights: SBI net profit up 5.6%, Swiggy trims loss in Q4, Hyundai profit declines, Urban Company loss widens, Titan, Kalyan Jewellers & Vedant Fashions Q4 profit up y-o-y, ABB I

Q4 Results Today, 08th May 2026 Highlights: Find all the latest Q4 results 2026 updates of 3i Infotech, ABB India, Aditya Consumer Marketing, Advance Agrolife, Aeroflex Neu, Ampvolts, Amrutanjan Health Care, Accretion Nutraveda, Apollo Finvest India, Aravali Securities & Finance, Archidply Industries, ArisInfra Solutions, Artemis Medicare Services, Aditya Vision, Bajaj Healthcare, Balkrishna Industries, Bank of Baroda, Bank of India, Bombay Dyeing & Manufacturing Company, Cera Sanitaryware, Cholamandalam Financial Holdings, CreditAccess Grameen, Continental Securities, Dai-Ichi Karkaria, DAPS Advertising, Epuja Spiritech, Family Care Hospitals, Gallops Enterprise, G N A Axles, Grindwell Norton, GSL Securities, Hyundai Motor India, Inspirisys Solutions, Intellect Design Arena, IRM Energy, Jet Solar, JK Agri Genetics, JSW Infrastructure, Kalyan Jewellers India, KP Green Engineering, Kalyani Steels, Lloyds Enterprises, L. T. Elevator, Vedant Fashions, Mac Charles India, Multi Commodity Exchange of India, Minaxi Textiles, Modern Shares & Stockbrokers, Monika Alcobev, Muthoot Capital Services, Nitin Spinners, Niva Bupa Health Insurance Company, Northern Arc Capital, Oberoi Realty, Omega Interactive Technologies, Orient Electric, Paramount Cosmetics India, Parmeshwar Metal, Prerna Infrabuild, Purity Flexpack, Rain Industries, Reetech International, Shree Renuka Sugars, Sasken Technologies, State Bank of India, Shipping Corporation of India, Sika Interplant Systems, Sueryaa Knitwear, Swiggy, Tata Consumer Products, Tips Films, Titan Company, TPI India, Ujjivan Small Finance Bank, Urban Company, Vivanta Industries, and V R Films & Studios. BSE, KVB, MRF, Dabur, Biocon, Thermax, Pidilite, Britannia, Lupin, ACME Solar, Shakti Pumps, MRF, Bharat Forge, CarTrade Tech, Wonderla Holidays and more in focus. Stay tuned for more updates from businessline

The Hindu Business LineMay 8, 2026

Q3 Results Highlights 4 February 2026: Trent, Apollo Tyres, Bajaj Holdings, Kalpataru Projects, Emami, Emcure Pharma log gains; Tata Power, Bajaj Finserv profits flat; NHPC dips

Q3 Results on 04th Feb 2026 Highlights: Find all the latest Q3 results 2026 updates of Bajaj Finserv, Trent, Bajaj Holdings & Investment, The Tata Power Company, Cummins India, NHPC, Tube Investments of India Ltd, Hexaware Technologies, Apollo Tyres, Global Health, Emcure Pharmaceuticals, Inventurus Knowledge Solutions, Force Motors, Timken India, Redington, Emami, Kalpataru Projects International, Century Plyboards, JSW Cement, Aptus Value Housing Finance India, Gallantt Ispat, CCL Products India, Sammaan Capital, Sandur Manganese and Iron Ores, RITES, Jubilant Ingrevia, Jaiprakash Power Ventures, Eureka Forbes, Metropolis Healthcare, Tamilnad Mercantile Bank, Transport Corporation of India, Westlife Foodworld, Archean Chemical Industries, Avalon Technologies, Cera Sanitaryware, Welspun Enterprises, Keystone Realtors, Lloyds Engineering Works, Quality Power Electrical Equipments, Aurionpro Solutions, Saatvik Green Energy, Zota Health Care, Wonderla Holidays, Parag Milk Foods, GRM Overseas, Automotive Axles, Greenply Industries, Apeejay Surrendra Park Hotels, Carysil, Pokarna, Jain Irrigation Systems, TeamLease Services, Xpro India, Rane Madras, Shipping Corporation of India Land and Assets, Ndr Auto Components, Shukra Pharmaceuticals, Asian Granito India, Associated Alcohol and Breweries, Ashika Credit Capital, Indo Tech Transformers, iValue Infosolutions, Andhra Paper Limited, Orient Green Power Company, Zuari Agro Chemicals, Advent Hotels International, Virtuoso Optoelectronics, Butterfly Gandhimathi Appliances, Oriental Rail Infrastructure, Wealth First Portfolio Managers, Tamilnadu Petroproducts, Ganesh Consumer Products, Sarla Performance Fibers, Allied Digital Services, Gloster, Voith Paper Fabrics, Transpek Industry, PTL Enterprises, India Homes, BMW Ventures, Orient Ceratech, Investment and Precision Castings, Visa Steel, SIL Investments, Kanpur Plastipacks, OCCL, Welspun Investments and Commercials, Manomay Tex India, Andhra Petro, Industrial Investment Trust, Indo-National, Shivam Autotech, U. Y. Fincorp, AG Ventures, Oxygenta Pharmaceutical, DRC Systems India, Virinchi, Kothari Sugars and Chemicals, JK Agri Genetics, Bhagwati Autocast, National Fittings, Resonance Specialities, Sunshine Capital, Silkflex Polymers, Texel Industries, Sellowrap Industries, Transcorp International, Skyline Millars, Vivid Mercantile, Oceanic Foods, Spright Agro, Aeonx Digital Technology, Yash Innoventures, Kamadgiri Fashion, Aro Granite Industries, Harshil Agrotech, NK Industries, Gujarat Terce Laboratories, Lamosaic India, Prakash Woollen & Synthetic Mills, TV Vision, Swarna Securities, Zenith Fibres, Abirami Financial Services (India), Rap Corp, Velan Hotels, Shivamshree Businesses, Sarvottam Finvest, Ushakiran Finance, Zodiac Ventures, and Unjha Formulations.

The Hindu Business LineFeb 4, 2026

Frequently asked questions

Is Cera a public or private company?

Cera is a private company as of the most recent data available. Its shares do not trade on a public stock exchange. Employees and early shareholders who want liquidity may need to explore secondary-market options or wait for a future IPO or acquisition.

What is Cera's valuation?

Cera's latest reported valuation is $1B, set during its Series C round. This is the preferred-stock valuation — the price per share that employees hold (common stock) is typically lower due to the liquidation preference stack. See our glossary entries on pre-money valuation and common stock for more detail.

What is Cera's stock price per share?

Cera does not trade on a public exchange, so there is no single live stock price. Indicative pricing may be available through secondary-market platforms. The most recent known valuation data ($1B) can help frame expectations, but common shares typically trade at a discount to the headline preferred-stock valuation.

When will Cera IPO?

Cera has not announced a confirmed IPO date. IPO timing depends on market conditions, company financials, and board decisions. Employees should plan around the possibility that liquidity may take years and consider whether secondary-market options or company-sponsored tender offers are available in the interim.

Can I sell my Cera stock?

It depends on what you hold and your company's policies. Vested, exercised shares are generally eligible for secondary-market sales, subject to Cera's transfer restrictions and right of first refusal (ROFR). Unexercised options and unvested RSUs typically cannot be sold. Some companies also run periodic tender offers that allow employees to sell a portion of their holdings at a set price. Check your equity agreement or speak with your stock plan administrator for Cera-specific rules.

How much does it cost to exercise Cera stock options?

The out-of-pocket cost equals your strike price multiplied by the number of shares you exercise. For ISOs, exercising may also trigger the Alternative Minimum Tax (AMT) based on the spread between your strike price and the current fair market value. For NSOs, the spread is taxed as ordinary income at exercise. Use our AMT Calculator and Stock Option Tax Calculator to model the cost for your specific situation.

What type of stock options does Cera grant — ISOs or NSOs?

Most venture-backed companies grant ISOs (Incentive Stock Options) to U.S. employees where possible, with NSOs (Non-Qualified Stock Options) used for amounts exceeding the $100K annual ISO limit, for contractors, or for non-U.S. employees. Your specific grant type is listed in your option agreement. The distinction matters because ISOs can qualify for long-term capital gains treatment, while NSOs are taxed as ordinary income at exercise. See our ISO guide and NSO guide for the full breakdown.

What happens to my Cera stock if the company is acquired?

In an acquisition, your equity outcome depends on the deal structure and your grant terms. Common scenarios include cash-out (your shares are bought at a set price per share), rollover (your shares convert into the acquirer's equity), or cancellation with an acceleration clause. If you have double-trigger acceleration, your unvested shares may accelerate only if you are also terminated. The liquidation preference stack determines how proceeds are divided — preferred shareholders are paid first, which can reduce or eliminate the payout to common shareholders in lower-value exits.

What is the difference between common and preferred Cera stock?

Employees typically hold common stock (or options on common stock). Investors hold preferred stock, which usually comes with a liquidation preference — meaning investors get paid first in an exit before common shareholders receive anything. Cera's $1B headline valuation reflects the preferred-stock price. The fair market value of common shares (used for your 409A and strike price) is typically 25–50% lower. This distinction is critical when estimating what your shares might actually be worth in an exit.

What happens to my Cera options if I leave?

When you leave a company, you typically have a limited post-termination exercise window — often 90 days — to exercise your vested options or they expire worthless. Some companies offer extended windows (up to 10 years). Unvested options are forfeited. If you hold ISOs and don't exercise within 90 days of leaving, they convert to NSOs, which changes the tax treatment. Review your option agreement for Cera's specific terms, and use our Exercise Timing Planner to model the financial tradeoffs.

Related pages

• All companies
• Healthcare & Biotech companies
• Companies in London
• Series C companies
• Schroders Capital portfolio
• BDT & MSD Partners portfolio
• Kairos HQ portfolio